Association between the use of calcimimetics and vitamin D receptor activators and fracture risk in patients undergoing maintenance hemodialysis: a cohort study
Abstract
Introduction Secondary hyperparathyroidism is a major complication of maintenance hemodialysis (MHD). Elevated serum parathyroid hormone levels increase fracture risk. We aimed to investigate the association between secondary hyperparathyroidism medication and fracture risk in patients undergoing MHD. Methods Patient data from a large medical claims database were used. Patients receiving MHD were divided into untreated, vitamin D receptor activator (VDRA), and calcimimetic groups. The outcome was the first hospitalization due to any fracture. First hospitalization for hip or vertebral fracture was evaluated. Hazard ratios (HRs) were assessed using a weighted Cox proportional hazards model with overlap weights. Results A total of 13,238, 4,847, and 5,977 patients comprised the untreated, VDRA, and calcimimetic groups, respectively. The untreated and calcimimetic groups showed a slightly lower incidence risk of any fracture than the VDRA group, although no significant difference was observed (HR, 0.85; 95% confidence interval [CI], 0.66-1.10 and HR, 0.84; 95% CI, 0.64-1.09, for the untreated and calcimimetic groups, respectively). Regarding hip fracture, the calcimimetic group exhibited a similar downward trend compared with any fracture, whereas the untreated group showed an incidence risk comparable with that of the VDRA group (HR, 0.91; 95% CI, 0.62-1.33 and HR, 0.77; 95% CI, 0.50-1.18, for the untreated and calcimimetic groups, respectively). The risk of vertebral fracture…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 5,977 participants or records.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.